ResMed Inc. Stock Sheds 9.1%, Underperforms Market
Dow Jones2026/10/30 20:34This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of ResMed Inc. slid 9.1% to $229.94 on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 1.8% to 7,580.07 and Dow Jones Industrial Average falling 1.1% to 51,770.31.
ResMed Inc. closed 17.2% short of its 52-week high of $277.67, which the company achieved on February 10th.
Trading volume totaled 3.4 million, compared to the 50-day average of 1.2 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 30, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Wedbush lowers the target price for Cerebras Systems to $190.
BUZZ-Zura Bio shares plummet after mid-stage trial failure of skin disease drug

Netcapital Gets Nasdaq Extension Until Feb. 9 to File Overdue Reports
